KIK - Updating Existing Software to Optimize Regulatory Infrastructure and Automate the Validation Process
KIK Custom Products was founded in 1995 in Concord, Ontario as a producer of private label bleach products for small Canadian retailers. After going public in 2002 and two key acquisitions in 2005, KIK made the move into contract manufacturing for national brands, expanding their manufacturing capabilities to include personal care, salon, pharmaceuticals, pool additives, household and industrial cleaning products and medical device products.
BIOGEN - Improving the Efficiency of Development Translational Medicine at Biogen
Biogen Idec (NASDAQ: BIIB) is the world’s oldest independent biotechnology company. Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The Development Translational Medicine team at Biogen uses imaging and a wide variety of cutting edge technologies to establish translational strategies to improve the likelihood of drug development success in neurodegenerative, inflammatory and blood diseases.
APOTEX - Implementing a More Efficient Validation Process Using Existing Technology
Apotex Inc. was founded in 1974, and is the largest Canadian-owned pharmaceutical company, employing 7,500 people in research, development, manufacturing and distribution facilities world-wide. Based in Toronto, Ontario the company’s pharmaceuticals can be found in virtually every pharmacy and healthcare facility in Canada and are exported to over 115 countries around the globe.